Showing 681-690 of 9402 results for "".
DermwireTV — Sun Rises, ICD-10 is Delayed…Again
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-sun-rises-icd-10-is-delayed-again/19139/In this week's DermwireTV, Sun acquires Ranbaxy, ICD-10 gets unexpectedly delayed, and Murad Alam recaps the ASLMS conference.ARTAS in Practice
https://practicaldermatology.com/topics/practice-management/artas-feinberg/19191/Dr. Feinberg describes how he incorporated the ARTAS Robotic Procedure into his practice.ARION, Alexandrite Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/arion-alexandrite-laser-system-by-quantel-derma/19377/ARION by Quantel Derma - High-end Solution for Hair Removal. ARION is the alexandrite laser system for effective hair removal with 755 nm wavelength. The versatile system is also suitable for treatment of vascular lesions and benign pigmented skin changes. The special Burst Mode with short sub-pulseHyaluronic Acid as Filler and Moisturizer
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hyaluronic-acid-as-filler-and-moisturizer/19420/Most people are common with hyaluronic acid being used as a filler to remove lines and wrinkles. However, it also serves as a great moisturizer when applied topically in the proper form. In this episode of DermTV, Dr. Schultz shares everything you need to know about hyaluronic acid.Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 4
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-4/56872/In the fourth installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, focus on how adjuvant skincare may influence treatment pathways, including delaying or optimizing escalation to systemic therapies.1 Draelos Z, Ho3 Years of Real-World Data for an AD Biologic
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/3-years-of-real-world-data-for-an-ad-biologic/50769/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Chief Medical Editor Neal Bhatia, MD, FAAD, discuss Dr. Bhatia’s article “Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-WorlDiagnostic Approach for Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/diagnostic-approach-for-prurigo-nodularis/37137/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, describes his diagnostic algorithm for prurigo nodularis.Antimicrobial Resistance and Psoriasis Remission
https://practicaldermatology.com/series/the-practical-dermatology-podcast/antimicrobial-resistance-and-psoriasis-remission/39042/Jason E. Hawkes, MD, MS, FAAD, discusses a recent consensus paper defining on-treatment remission for plaque psoriasis, and Theodore Rosen, MD, FAAD, joins associate medical editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss the threat posed by antimicrobial resistance and play “Two Truths and aImproving Adherence to Topical Regimens
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/improving-adherence-to-topical-regimens/48780/Zoe Diana Draelos, MD, discusses strategies for improving adherence to topical regimens in chronic atopic dermatitis.Anti-OX40 Ligand Antibody Trials
https://practicaldermatology.com/series/updates-atopic-dermatitis/anti-ox40-ligand-antibody-trials/29531/Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, discusses the phase 2b STREAM-AD trial, evaluating amlitelimab in adult patients with moderate-to-severe atopic dermatitis.